DuPont de Nemours, Inc. (NYSE:DD – Get Free Report) has received an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $54.5714.
DD has been the subject of several recent analyst reports. BMO Capital Markets upped their price objective on shares of DuPont de Nemours from $25.10 to $60.00 and gave the company an “outperform” rating in a research note on Tuesday. Mizuho upped their price objective on shares of DuPont de Nemours from $46.00 to $52.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. Argus lowered their price objective on shares of DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating for the company in a research note on Thursday, February 5th. KeyCorp upped their price objective on shares of DuPont de Nemours from $51.00 to $57.00 and gave the company an “overweight” rating in a research note on Wednesday, February 11th. Finally, UBS Group upped their price objective on shares of DuPont de Nemours from $49.00 to $56.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th.
Check Out Our Latest Research Report on DD
Hedge Funds Weigh In On DuPont de Nemours
DuPont de Nemours Stock Performance
NYSE DD opened at $49.23 on Wednesday. The company has a 50-day simple moving average of $46.47 and a two-hundred day simple moving average of $43.14. The company has a quick ratio of 1.91, a current ratio of 2.42 and a debt-to-equity ratio of 0.22. DuPont de Nemours has a 12-month low of $26.82 and a 12-month high of $52.66. The firm has a market cap of $20.18 billion, a price-to-earnings ratio of -26.47, a PEG ratio of 1.57 and a beta of 1.02.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.07. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the business posted $1.03 earnings per share. The company’s revenue was up 4.3% on a year-over-year basis. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. On average, equities analysts forecast that DuPont de Nemours will post 2.27 EPS for the current year.
DuPont de Nemours Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 15th. DuPont de Nemours’s dividend payout ratio is -43.01%.
Key Stories Impacting DuPont de Nemours
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Q1 beat and productivity-driven profit improvement — DuPont reported adjusted EPS of $0.55 vs. consensus $0.48 and revenue of ~$1.68B, with management citing productivity gains and demand strength in healthcare and aerospace. DD Q1 Earnings Beat on Productivity Gains, Sales Rise Y/Y
- Positive Sentiment: Raised guidance — Management lifted FY?2026 adjusted EPS guidance to $2.35–$2.40 (above consensus) and set Q2 EPS at $0.59, signaling stronger expected full?year results. DuPont Reports First Quarter 2026 Results
- Positive Sentiment: $275M accelerated share repurchase and buyback plan — The company announced an imminent $275 million ASR, returning capital and supporting EPS per share going forward. DuPont Lifts Outlook, Plans $275 Million Buyback
- Positive Sentiment: Analyst upgrade and higher price target — BMO Capital Markets raised its price target to $60 and kept an “outperform” rating, adding upside to the stock’s outlook. BMO Capital Adjusts Price Target on DuPont
- Neutral Sentiment: Operational cash flow and EBITDA — Q1 cash from operations was ~$232M, transaction?adjusted free cash flow ~$147M, and operating EBITDA ~$414M, supporting the stronger guidance but leaving leverage/capital allocation choices in focus. DuPont Reports First Quarter 2026 Results
- Neutral Sentiment: Completed Aramids divestiture — The April 1 sale was closed, simplifying the portfolio and affecting reported segment comparatives. DuPont Reports First Quarter 2026 Results
- Neutral Sentiment: Full earnings materials and call available — Investors can review the earnings slide deck and transcript for detail on segment trends and margin drivers. Q1 Slide Deck Earnings Call Transcript
- Negative Sentiment: EPS remains below prior?year level — Adjusted EPS improved vs. expectations but is lower than the year?ago quarter (~$1.03), indicating recovery is underway but not complete. MarketBeat Q1 Summary
DuPont de Nemours Company Profile
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Featured Stories
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
